Jun Guo

Molecular mechanism of Poria cocos combined with oxaliplatin on the inhibition of in gastric cancer cells

Na Wang, Dengxiang Liu, Jun Guo et al. · Biomedicine & Pharmacotherapy · 2018 · 30 citations

Medicine, Oncology, Pharmacology +12

Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial

Xiao Han, Jun Guo, Lingyu Li et al. · Signal Transduction and Targeted Therapy · 2024 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial

Xiao Han, Xiaoyong Tang, Hui Zhu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab

Haiyong Wang, Qinge Shan, Jun Guo et al. · Lung Cancer · 2020 · 22 citations

Medicine, Molecular Genetics, Oncology +14

An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)

Xiang Wang, Ruixing Zhang, Nan Du et al. · Therapeutic Advances in Medical Oncology · 2020 · 21 citations · Full text

Medicine, Oncology, Pharmacology +13